Your cart is currently empty
Product image slideshow Items
• Probiotic for Women with 25+ Years of Research That Supports Benefits For Vaginal and Urinary Tract Health • Clinically-Documented Benefits • More Than 20 Studies Demonstrating Safety and Efficacy • Patented Lactobacilli Strains: GR-1® and RC-14®
Available in storeClose
Fem-Dophilus® contains two patented and clinically documented probiotic strains, Lacticaseibacillus rhamnosus GR-1®‡ and Limosilactobacillus reuteri RC-14®‡, discovered and developed by Dr. Gregor Reid and Dr. Andrew Bruce at Urex Biotech. Over 25 years of research supports the oral use of GR-1® and RC-14® to colonize and promote healthy vaginal and urinary tract health.* A special manufacturing process protects the probiotic strains in Fem-Dophilus® from stomach acid and enhances probiotic bacterial survival to the lower intestine.
‡Updates based on official taxonomy reclassification.
GR-1®/RC-14® and VAGINAL FLORA (also called microbiota)
In one of the randomized clinical trials, 75% of women in the GR-1®/RC-14® probiotic group experienced significant improvement in vaginal flora composition, while only 34% of women in the placebo (non-probiotic) group experienced similar improvement.